IBM Israel has granted Israel’s Teva access to its Watson supercomputing Health Cloud program. Teva plans to use the global technology platform to design treatments for millions of people who suffer from chronic conditions like asthma, migraine, and pain.
IBM and Teva team up to find chronic treatments
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.